• Working with

    passion, integrity,
    & true innovation

  • Developing

    novel, first-in-class therapeutics

  • Targeting

    major unmet medical needs

  • Changing

    the approach to
    treating cancer

Imetelstat

First-in-class, first-in-clinic,
telomerase inhibitor

 

Telomerase

Learn about our innovative approach to developing a treatment for cancer

 

Geron Announces
Collaboration with Janssen

Click here for important information

 

Geron News

8.5.2015

Geron Corporation Reports Second Quarter 2015 Financial Results

Read More

4.30.2015

Geron Corporation Reports First Quarter 2015 Financial Results and Recent Events

Read More

4.27.2015

Geron to Present at the Bank of America Merrill Lynch Healthcare Conference

Read More

 

Events

05.18.2015

Geron 2015 Annual Meeting

Listen to Webcast

04.14.2015

Geron Presents at the 14th Annual Needham Healthcare Conference

Listen to Webcast

Download Presentation

02.09.2015

Geron Presents at the 17th Annual BIO CEO & Investor Conference

Listen to Webcast

Download Presentation